In Re: Prempro Products et al
Pharmacia & Upjohn Company, Abbott Laboratories, Warner Lambert Company LLC, SmithKline Beecham Corporation, Gallipot Inc, Valeant Pharmaceuticals International, American College of Obstetricians and Gynecologists, Monarch Pharmaceuticals Inc, Wyeth Pharmaceuticals Inc, Pfizer Inc, Ortho McNeil Pharmaceutical Inc, Bristol Myers Squibb Company, USL Pharma Inc, Solvay America Inc, Amarin Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Schering AG, Pharmacia Company, Sage Pharmaceuticals Inc, Duramed Pharmaceuticals Inc, Organon USA Inc, Novo Nordisk Inc, Barr Pharmaceuticals Inc, Watson Laboratories Inc, Wyeth Inc, Elan Pharmaceuticals Inc, Solvay Pharmaceuticals Inc, Mylan Laboratories Inc, Galen Holdings PLC, Warner Chilcott, Berlex Inc, Novavax Inc, Abbot Laboratories Inc, Barr Laboratories Inc, Aventis Pharmaceuticals Inc, Greenstone Ltd, American College of Physicians, Dannemiller Memorial Educational Foundation, Pharmacia Corporation, King Pharmaceuticals Inc, Watson Pharmaceuticals Inc, Wyeth Ayerst Pharmaceuticals Inc, Novo Nordisk Pharmaceuticals Inc and American Home Products |
Fred Hutchinson Cancer Research Center |
New York Times Company |
Rex Kyle |
Hon. James Rosenbaum |
Prempro Products Liability Litigation |
GlaxoSmithKline Consumer Healthcare |
4:2003cv01507 |
March 7, 2003 |
U.S. District Court for the Eastern District of Arkansas |
L Office |
Billy Roy Wilson |
Personal Inj. Prod. Liability |
28 U.S.C. § 1332 Diversity-Product Liability |
Both |
Docket Report
This docket was last retrieved on October 30, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 3330 Sixth MOTION for Disbursement of Funds OF COMMON BENEFIT FEE COMMITTEES UNAMIMOUS MOTION FOR SIXTH DISTRIBUTION OF COMMOTION for Disbursement of FundsMON BENEFIT FUNDS by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3328 MOTION to Withdraw as Attorney John P. Borger by Novartis Pharmaceuticals Corporation (Svitak, Linda) |
![]() |
Filing 3326 MOTION to Withdraw as Attorney James A. O'Neal as Counsel of Record by Novartis Pharmaceuticals Corporation (Borger, John) |
![]() |
![]() |
Filing 3323 MOTION to Substitute Attorney by Watson Pharmaceuticals Inc (Wilson, Kyle) |
![]() |
![]() |
Filing 3320 MEMORANDUM re #3319 Fifth MOTION for Disbursement of Funds . (Attachments: #1 Proposed Order)(Walker, Erik) |
Filing 3319 Fifth MOTION for Disbursement of Funds by All Plaintiffs (Attachments: #1 Appendix)(Walker, Erik) |
![]() |
Filing 3317 MEMORANDUM re #3316 Fourth MOTION for Disbursement of Funds filed by Counsel Plaintiff Lead. (Attachments: #1 Appendix A)(Walker, Erik) |
Filing 3316 Fourth MOTION for Disbursement of Funds by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
![]() |
NOTICE OF DOCKET CORRECTION re: #3313 Proposed Order. CORRECTION: The docket text was modified to indicate the document was filed in error. (thd) |
Filing 3313 DOCUMENT (proposed order) FILED IN ERROR - DISREGARD. (Walker, Erik) (Docket text modified on 9/18/2015.) (thd). |
Filing 3312 MEMORANDUM re #3311 MOTION for Disbursement of Funds COMMON BENEFIT FEE COMMITTEES UNAMIMOUS MOTION FOR THIRD DISTRIBUTION OF COMMON BENEFIT FUNDS filed by Counsel Plaintiff Lead. (Attachments: #1 Appendix A)(Walker, Erik) |
Filing 3311 MOTION for Disbursement of Funds COMMON BENEFIT FEE COMMITTEES UNAMIMOUS MOTION FOR THIRD DISTRIBUTION OF COMMON BENEFIT FUNDS by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
![]() |
Filing 3308 ADDENDUM filed by Counsel Plaintiff Lead to #3307 Reply to Response to Motion,. Exhibit 1 (Walker, Erik) |
Filing 3307 REPLY to Response to Motion re #20 Motion to Amend/Correct PLAINTIFFS MOTION TO ENFORCE PRACTICE AND PROCEDURE ORDER NO. 6 filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1 (placeholder- Exhibit filed under seal), #2 Exhibit 2, #3 Exhibit 3)(Walker, Erik) |
Filing 3306 RESPONSE to Motion re #3302 MOTION for Order PLAINTIFFS MOTION TO ENFORCE PRACTICE AND PROCEDURE ORDER NO. 6 filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Wetherall, Peter) |
Filing 3305 RESPONSE to Motion re #3302 MOTION for Order PLAINTIFFS MOTION TO ENFORCE PRACTICE AND PROCEDURE ORDER NO. 6 filed by Pfizer Inc, Pharmacia & Upjohn Company, Pharmacia Company, Pharmacia Corporation, Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Heard, F.) |
![]() |
Filing 3303 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson:Telephone Conference held on 11/5/2014. Arguments made regarding motion #3302 . Atty. Walker is to prepare a proposed order and email it to all the parties and the Court. Responses to the motion are due by Wednesday, Nov. 12, 2014 and replies are due by Wednesday, Nov. 19, 2014. Counsel on the conference: Rainey Booth, Erik Walker, Lane Heard, William Hoofman, Peter Wetherall and Sherri Forbes. (Court Reporter Christa Jacimore.) (mmb) |
Filing 3302 MOTION for Order PLAINTIFFS MOTION TO ENFORCE PRACTICE AND PROCEDURE ORDER NO. 6 by Counsel Plaintiff Lead (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Walker, Erik) |
Filing 3301 NOTICE of Settlement AND DETERMINATION OF INAPPLICABILITY OF PRACTICE & PROCEDURE ORDER (PPO) # 6 by Counsel Plaintiff Liaison (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Wetherall, Peter) |
![]() |
![]() |
Filing 3298 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson:Telephone Conference held on 7/25/2014 to discuss pleading filed by Atty. Littlepage and Atty. Walker. Court will send notice to all other counsel that deadline to respond to common benefit fund disbursement is July 31, 2014. Participants: Zoe Littlepage, Eric Walker, Ralph Cloar, Rob Jenner, Tobi Millrood, Mike Williams and Irwin Levin. (Court Reporter Christa Jacimore.) (mmb) |
![]() |
Filing 3296 RESPONSE re #3295 Order, ZOE LITTLEPAGES AND ERIK WALKERS SUBMISSION OF AGREEMENT RE: COMMON BENEFIT FUND by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3294 RESPONSE re #3289 Order, ERIK WALKERS SUBMISSION RE: COURTS INQUIRY ON COMMON BENEFIT FEE ALLOCATION by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3292 RESPONSE re #3289 Order, Letter to Judge Wilson from Zoe Littlepage by Counsel Plaintiff Lead (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Littlepage, Zoe) |
Filing 3291 MOTION for Extension of Time to File Response/Reply as to #3289 Order, CBFC AND ERIK WALKERS MOTION FOR ENLARGEMENT OF TIME by Counsel Plaintiff Lead (Walker, Erik) |
Filing 3290 NOTICE OF DOCKET CORRECTION re: #3289 Order. CORRECTION: The original document contained clerical errors; the correct document was added as an attachment to docket entry #3289 and is attached hereto for service on the parties. (thd) |
![]() |
Filing 3288 MEMORANDUM re #3287 MOTION for Disbursement of Funds THE CBFCS UNANIMOUS MOTION FOR PERCENTAGE ALLOCATION OF COMMON BENEFIT FUND AND FOR SECOND DISBURSEMENT OF FUNDS filed by Counsel Plaintiff Lead. (Attachments: #1 Appendix A, #2 Appendix B, #3 Appendix C, #4 Exhibit 1, #5 Exhibit 2)(Walker, Erik) |
Filing 3287 MOTION for Disbursement of Funds THE CBFCS UNANIMOUS MOTION FOR PERCENTAGE ALLOCATION OF COMMON BENEFIT FUND AND FOR SECOND DISBURSEMENT OF FUNDS by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3285 MEMORANDUM re #3284 MOTION for Disbursement of Funds The CBFC's First Request for Disbursement of Common Benefit Funds filed by Counsel Plaintiff Lead. Memorandum in Support of the CBFC's First Request for Disbursement of Common Benefit Funds (Attachments: #1 Appendix A, #2 Appendix B, #3 Appendix C)(Walker, Erik) |
Filing 3284 MOTION for Disbursement of Funds The CBFC's First Request for Disbursement of Common Benefit Funds by Counsel Plaintiff Lead (Walker, Erik) |
Filing 3283 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 4/22/14. (tjb) |
![]() |
NOTICE OF DOCKET CORRECTION re: 3280 Stipulation and Findings. CORRECTION: Pursuant to instructions from the Court, the document was removed from the docket and the docket text was modified to indicate the document was filed in error. (thd) |
Filing 3281 NOTICE OF DOCKET CORRECTION 3280 Stipulation and Findings. CORRECTION: The document with the certificate of service was added as an attachment to docket entry 3280 , based on the attached correspondence. (thd) |
Filing 3280 DOCUMENT FILED IN ERROR - DISREGARD. (Littlepage, Zoe) (The document was removed from the docket on 4/4/2014, pursuant to instructions from the Court.) (thd). |
![]() |
![]() |
![]() |
![]() |
![]() |
NOTICE OF DOCKET CORRECTION re: #3275 Order Vacating Conditional Remand Order. CORRECTION: The docket text was modified to indicate the Order was signed by the Clerk of the Judicical Panel on Multidistrict Litigation. (thd) |
Filing 3274 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding the attached listed cases to their transferor courts. Signed by the Clerk of the Panel on 1/14/14. (tjb) |
![]() |
![]() |
Filing 3271 NOTICE by Counsel Plaintiff Lead re #3267 Order Letter from Erik Walker on Contingent Fees (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Walker, Erik) |
Filing 3270 REPLY re #3267 Order Letter to Hon. Judge Wilson from G. Sean Jez by Counsel Plaintiff Liaison. (Jez, G.) |
Filing 3269 NOTICE by Counsel Plaintiff Lead re #3267 Order Letter to Judge Wilson from Zoe Littlepage (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Littlepage, Zoe) |
![]() |
![]() |
![]() |
Filing 3265 RESPONSE to Motion re #3263 MOTION to Strike #3262 Reply (Non Motion),,, #3261 Reply (Non Motion), MOTION TO STRIKE UNAUTHORIZED SUR-REPLY BRIEFS OR IN THE ALTERNATIVE MOTION FOR LEAVE TO RESPOND filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3264 NOTICE by Prempro Products Liability Litigation re #3237 Notice (Other), Notice of Amendment to the Common Benefit Fee Committee's Recommendation (Millrood, Tobias) |
Filing 3263 MOTION to Strike #3262 Reply (Non Motion),,, #3261 Reply (Non Motion), MOTION TO STRIKE UNAUTHORIZED SUR-REPLY BRIEFS OR IN THE ALTERNATIVE MOTION FOR LEAVE TO RESPOND by Counsel Plaintiff Lead (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Walker, Erik) |
Filing 3262 REPLY re #3260 Reply (Non Motion), The Littlepage Firm's Sur-Reply to CBFC's Reply to Objection to Common Benefit Fee Committee's Recommendation for Fee and Expense Allocation by The Littlepage Firm by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30)(Littlepage, Zoe) (NOTE: Document STRICKEN on 12/23/2013 per 3266 Order.)(thd). |
Filing 3261 REPLY re #3260 Reply (Non Motion), CBFC's Reply to Objection to Common Benefit Fee Committee's Recommendation for Fee and Expense Allocation by Rainey C. Booth PA by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Booth, Rainey) (NOTE: Document STRICKEN on 12/23/2013 per 3266 Order.) (thd). |
Filing 3260 REPLY re #3253 Notice (Other),, #3251 Notice (Other),,,, #3252 Addendum,,,, The Common Benefit Fee Committee's Reply to The Objections to the Common Benefit Fee Committee's Recommendation for Fee and Expense Allocation by The Littlepage Firm and Rainey Booth P.A. by Counsel Plaintiff Lead. (Attachments: #1 Appendix Cover Sheet of Appendix Filed Under Seal, #2 Exhibit Cover Sheet of Exhibits Filed Under Seal)(Walker, Erik) |
Filing 3259 REPLY re #3250 Notice (Other) Common Benefit Fee Committee's Reply to Wetherall Group, Ltd.'s Notice of Objection by Counsel Plaintiff Lead. (Attachments: #1 Exhibit Exhibits Filed Under Seal Cover Sheet)(Walker, Erik) |
NOTICE OF DOCKET CORRECTION re: #3258 Joint MOTION to Dismiss. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case).(thd) |
Filing 3258 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Lysaught, Patrick) (Docket text modified on 12/5/2013.) (thd). |
![]() |
Filing 3256 BRIEF IN SUPPORT re #3255 Motion for Order Memorandum In Support of The Common Benefit Fee Committee's Motion for Order Instructing Trustee to Release Common Benefit Funds for Master filed by Counsel Plaintiff Lead. (Walker, Erik) |
Filing 3255 MOTION for Order The Common Benefit Fee Committee's Motion for Order Instructing Trustee to Release Common Benefit Funds for Master by Counsel Plaintiff Lead (Walker, Erik) |
Filing 3254 STATUS REPORT Re PPO-9 Discovery by Pfizer Inc, Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3253 NOTICE by Counsel Plaintiff Lead Rainey Booth's Objections to Common Benefit Fee Committee's Recommended Allocation for Common Benefit Time & Expenses (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19)(Booth, Rainey) |
Filing 3252 ADDENDUM filed by Counsel Plaintiff Lead to #3251 Notice (Other),,,,. The Littlepage Firm's Objections to Common Benefit Fee Committee's Recommended Allocation for Common Benefit Time and Expenses (Attachments: #1 Exhibit 51, #2 Exhibit 52, #3 Exhibit 53, #4 Exhibit 54, #5 Exhibit 55, #6 Exhibit 56, #7 Exhibit 57, #8 Exhibit 58, #9 Exhibit 59, #10 Exhibit 60, #11 Exhibit 61, #12 Exhibit 62, #13 Exhibit 63, #14 Exhibit 64, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 67, #18 Exhibit 68, #19 Exhibit 69, #20 Exhibit 70, #21 Exhibit 71, #22 Exhibit 72, #23 Exhibit 73, #24 Exhibit 74, #25 Exhibit 75, #26 Exhibit 76, #27 Exhibit 77, #28 Exhibit 78, #29 Exhibit 79, #30 Exhibit 80, #31 Exhibit 81, #32 Exhibit 82, #33 Exhibit 83, #34 Exhibit 84, #35 Exhibit 85, #36 Exhibit 86, #37 Exhibit 87, #38 Exhibit 88, #39 Exhibit 89, #40 Exhibit 90, #41 Exhibit 91)(Littlepage, Zoe) |
Filing 3251 NOTICE by Counsel Plaintiff Lead The Littlepage Firm's Objections to Common Benefit Fee Committee's Recommended Allocation for Common Benefit Time and Expenses (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50)(Littlepage, Zoe) |
Filing 3250 NOTICE by Counsel Plaintiff Lead Wetherall Group, Ltd.'s Notice of Objection (Wetherall, Peter) |
![]() |
![]() |
![]() |
Filing 3245 MOTION to Withdraw as Attorney for M. King Hill III by Abbot Laboratories Inc, Abbott Laboratories (Gaarder, Christina) |
Filing 3244 NOTICE by Counsel Plaintiff Lead re #3242 Order, COMMON BENEFIT FEE COMMITTEES SUBMISSION RE: APPOINTMENT OF MASTER (Walker, Erik) |
Filing 3243 NOTICE by Counsel Plaintiff Lead re #3242 Order, Lead Counsel's Response Re: Appointment of Special Master (Littlepage, Zoe) |
![]() |
Filing 3241 NOTICE by Prempro Products Liability Litigation re #3230 Util - Set/Reset Motion and R&R Deadlines/Hearings, Order (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Wetherall, Peter) |
Filing 3240 ADDENDUM filed by Counsel Plaintiff Lead to #3238 Notice (Other). Lead Counsel's Recommended Allocation for Common Benefit Time (Attachments: #1 Exhibit 51, #2 Exhibit 52, #3 Exhibit 53, #4 Exhibit 54, #5 Exhibit 55, #6 Exhibit 56, #7 Exhibit 57, #8 Exhibit 58, #9 Exhibit 59, #10 Exhibit 60, #11 Exhibit 61, #12 Exhibit 62, #13 Exhibit 63, #14 Exhibit 64, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 67, #18 Exhibit 68, #19 Exhibit 69, #20 Exhibit 70, #21 Exhibit 71, #22 Exhibit 72, #23 Exhibit 73, #24 Exhibit 74, #25 Exhibit 75, #26 Exhibit 76, #27 Exhibit 77, #28 Exhibit 78, #29 Exhibit 79, #30 Exhibit 80, #31 Exhibit 81, #32 Exhibit 82, #33 Exhibit 83, #34 Exhibit 84, #35 Exhibit 85, #36 Exhibit 86, #37 Exhibit 87, #38 Exhibit 88, #39 Exhibit 89, #40 Exhibit 90, #41 Exhibit 91, #42 Exhibit 92, #43 Exhibit 93, #44 Exhibit 94, #45 Exhibit 95, #46 Exhibit 96, #47 Exhibit 97, #48 Exhibit 98, #49 Exhibit 99, #50 Exhibit 100, #51 Exhibit 101, #52 Exhibit 102, #53 Exhibit 103, #54 Exhibit 104, #55 Exhibit 105, #56 Exhibit 106, #57 Exhibit 108, #58 Exhibit 109, #59 Exhibit 110, #60 Exhibit 111, #61 Exhibit 112, #62 Exhibit 113, #63 Exhibit 114, #64 Exhibit 115, #65 Exhibit 116, #66 Exhibit 117, #67 Exhibit 118, #68 Exhibit 119, #69 Exhibit 120, #70 Exhibit 121, #71 Exhibit 122, #72 Exhibit 123, #73 Exhibit 124, #74 Exhibit 125, #75 Exhibit 126, #76 Exhibit 127, #77 Exhibit 128, #78 Exhibit 129, #79 Exhibit 130, #80 Exhibit 131, #81 Exhibit 132, #82 Exhibit 133, #83 Exhibit 134, #84 Exhibit 135, #85 Exhibit 136, #86 Exhibit 137, #87 Exhibit 138, #88 Exhibit 139, #89 Exhibit 140, #90 Exhibit 141, #91 Exhibit 142, #92 Exhibit 143, #93 Exhibit 144, #94 Exhibit 145, #95 Exhibit 146)(Littlepage, Zoe) |
Filing 3239 ADDENDUM filed by Counsel Plaintiff Lead to #3238 Notice (Other). Lead Counsel's Recommended Allocation for Common Benefit Time (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50)(Littlepage, Zoe) |
Filing 3238 NOTICE by Counsel Plaintiff Lead Lead Counsel's Recommended Allocation for Common Benefit Time (Littlepage, Zoe) |
Filing 3237 NOTICE by Counsel Plaintiff Lead COMMON BENEFIT FEE COMMITTEES RECOMMENDATION FOR FEE AND EXPENSE ALLOCATION (Attachments: #1 Appendix A, #2 Appendix B, #3 Appendix C, #4 Appendix D, #5 Appendix E, #6 Appendix F, #7 Appendix G, #8 Exhibit 1, #9 Exhibit 2, #10 Exhibit 3)(Walker, Erik) |
Filing 3236 NOTICE by Counsel Plaintiff Lead re #3230 Util - Set/Reset Motion and R&R Deadlines/Hearings, Order COMMON BENEFIT FEE COMMITTEES SUBMISSION RE POTENTIAL APPOINTMENT OF SPECIAL MASTER (Walker, Erik) |
Filing 3235 NOTICE by Counsel Plaintiff Lead re #3230 Util - Set/Reset Motion and R&R Deadlines/Hearings, Order The Littlepage Firm's Request for Special Master (Littlepage, Zoe) |
Filing 3234 NOTICE by Counsel Plaintiff Lead re #3230 Util - Set/Reset Motion and R&R Deadlines/Hearings, Order Rainey Booth's Request for Special Master (Booth, Rainey) |
![]() |
Filing 3232 NOTICE OF DOCKET CORRECTION re: #3231 MOTION for Extension of Time to File COMMON BENEFIT FEE COMMITTEE'S MOTION. CORRECTION: The correct document was added as an attachment to docket entry #3231 based on the attached correspondence. (thd) |
Filing 3231 MOTION for Extension of Time to File COMMON BENEFIT FEE COMMITTEE'S MOTION by Counsel Plaintiff Lead (Walker, Erik) (Additional attachment(s) added on 11/4/2013: #1 Main Document - Correct) (thd). |
![]() |
Filing 3229 DOCUMENT FILED IN ERROR - DISREGARD (wrong case) (Bertram, Benjamin) (Docket text modified on 10/7/2013.) (thd). |
Filing 3228 DOCUMENT FILED IN ERROR - DISREGARD (wrong case) (Bertram, Benjamin) (Docket text modified on 10/7/2013.) (thd). |
Filing 3227 NOTICE by Counsel Plaintiff Lead BRIEF REJOINDER TO REPLY IN SUPPORT OF ZOE LITTLEPAGES MOTION FOR ALLOCATION FROM PLAINTIFFS COMMON BENEFIT FEE COMMITTEE (CBFC) (Walker, Erik) |
NOTICE OF DOCKET CORRECTION re: #3228 and #3229 MOTIONS to Dismiss. CORRECTION: The docket text for each entry was modified to indicate the document was filed in error (wrong case). (thd) |
Filing 3226 REPLY to Response to Motion re #3221 MOTION for Order Zoe Littlepage's Motion for Allocation From Plaintiff's Common Benefit Fee Committee filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3225 RESPONSE in Opposition re #3223 MOTION for Order Rainey Booth's Motion for Allocation from Plaintiff's Common Benefit Fee Committee, #3221 MOTION for Order Zoe Littlepage's Motion for Allocation From Plaintiff's Common Benefit Fee Committee filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12)(Walker, Erik) |
Filing 3224 BRIEF IN SUPPORT re #3223 Motion for Order Rainey Booth's Motion for Allocation from Plaintiff's Common Benefit Fee Committee filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Booth, Rainey) |
Filing 3223 MOTION for Order Rainey Booth's Motion for Allocation from Plaintiff's Common Benefit Fee Committee by Counsel Plaintiff Lead (Booth, Rainey) |
Filing 3222 BRIEF IN SUPPORT re #3221 Motion for Order Zoe Littlepage's Motion for Allocation From Plaintiff's Common Benefit Fee Committee filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14)(Littlepage, Zoe) |
Filing 3221 MOTION for Order Zoe Littlepage's Motion for Allocation From Plaintiff's Common Benefit Fee Committee by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
Filing 3219 RESPONSE in Opposition re #3214 MOTION for Order Motion for Independent Auditor filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Walker, Erik) |
![]() |
Filing 3217 MOTION to Extend Time HRT Common Benefit Fee Committee's Motion for Enlargement of Time to Respond to Zoe Littlepage's Motion for Independent Auditor by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3215 BRIEF IN SUPPORT re #3214 Motion for Order filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11)(Littlepage, Zoe) |
Filing 3214 MOTION for Order Motion for Independent Auditor by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 3213 NOTICE of Hearing: Status Conference on PPO5 and Common Benefit and Expense Issues set for 12/13/2013 at 9:00 AM in Little Rock, Courtroom # A401, before Judge Billy Roy Wilson. (mmb) |
![]() |
Filing 3211 MOTION for Order FOR SCHEDULING ORDER RELATING TO PPO #5 AND COMMON BENEFIT FEE AND EXPENSE PROCEEDINGS by All Plaintiffs (Millrood, Tobias) |
![]() |
Filing 3209 BRIEF IN SUPPORT re #3208 Motion for Order Lead Counsel's Motion for Scheduling Order filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3208 MOTION for Order Lead Counsel's Motion for Scheduling Order by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
Filing 3206 MOTION to Withdraw as Attorney by Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc (Gaines, Gail) |
Filing 3205 NOTICE OF DOCKET CORRECTION re: #3204 MOTION for Judgment on the Pleadings. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case), based on the attached correspondence. (thd) |
Filing 3204 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Bernier, Jan) (Docket text modified on 7/11/2013.) (thd). |
Filing 3203 NOTICE by Counsel Plaintiff Lead Correspondence to Judge Wilson Re: Bartlett decision (Walker, Erik) |
![]() |
Filing 3201 BRIEF IN SUPPORT re #3200 Motion for Order for Release of Common Benefit Funds From HT Litigation Fund to Reimburse Certain Law Firms For Capital Contributions filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit A)(Littlepage, Zoe) |
Filing 3200 MOTION for Order for Release of Common Benefit Funds From HT Litigation Fund to Reimburse Certain Law Firms For Capital Contributions by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
Filing 3198 MOTION to Withdraw as Attorney by Ortho McNeil Pharmaceutical Inc (Vines, James) |
Filing 3197 NOTICE of Appearance by Kimberly L. Beck on behalf of Watson Pharmaceuticals Inc (Beck, Kimberly) |
![]() |
Filing 3195 MOTION to Withdraw as Attorney (John Vardaman) by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
Filing 3193 MOTION to Withdraw as Attorney , MOTION to Substitute Attorney () by Organon USA Inc (Lodato, Vincent) |
![]() |
NOTICE OF DOCKET CORRECTION re: #3190 SECOND AMENDED NOTICE DEPOSITION DR PAPADEMITRIO. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case).(thd) |
Filing 3191 MOTION to Withdraw as Attorney and for Substitution by All Plaintiffs (Friedman, Andrew) |
Filing 3190 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Kolenich, Erika) Docket text modified on 4/9/2013 (thd). |
Filing 3189 STATUS REPORT Re PPO-9 Discovery by Pfizer Inc, Pharmacia & Upjohn Company, Pharmacia Company, Pharmacia Corporation, Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3188 NOTICE OF DOCKET CORRECTION re: #3187 Status Report. CORRECTION: The correct Exhibit 1 was added as an attachment to docket entry #3187 , based on the attached correspondence. (thd) |
Filing 3187 STATUS REPORT Joint Status Report Re PPO-9 Discovery by Pfizer Inc, Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) (Additional attachment(s) added on 3/18/2013: #2 Exhibit 1 - Correct) (thd). |
![]() |
![]() |
Filing 3184 MOTION to Withdraw as Attorney by Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc (Jones, Glenn) |
![]() |
Filing 3182 MOTION to Withdraw as Attorney by Novo Nordisk Inc (Denton, Deborah) |
![]() |
Filing 3180 BRIEF IN SUPPORT re #3179 Motion for Order For Release of Common Benefit Funds From HT Litigation Fund To Reimburse Law Firms For Capital Contributions filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3179 MOTION for Order For Release of Common Benefit Funds From HT Litigation Fund to Reimburse Law Firms For Capital Contributions by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
Filing 3177 MOTION to Extend Time to Respond to Barr Pharmaceuticals, LLC's and Barr Laboratories, Inc.'s Motions for Judgment on the Pleadings in Various MDL Cases by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
Filing 3175 TRANSCRIPT OF STATUS CONFERENCE Proceedings held on 1/25/2013, before Judge Bill Wilson. Court Reporter: Cheryl Nelson Kellar. Transcript may be viewed only at the public terminals in the Clerk's office. Copies of transcript are only available through the Official Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. DEADLINES: Notice of Intent to Request Redaction due 2/11/2013. Redaction Request due 2/21/2013. Redacted Transcript Deadline set for 3/4/2013. Release of Transcript Restriction set for 5/1/2013. (dmn) |
![]() |
![]() |
Filing 3172 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson: Status Conference held on 1/25/2013. Plaintiffs: Zoe Littlepage, Erik Walker, Ralph Cloar, Mike Williams, Peter van den Boom, Seth Webb, Chet Finley, Gary Holt, Mark Taylor, Tom McGowan, Melissa Luce, Josh Cusick, Breean Walas, David Deering, Alex Boone, Peter Wetherall, Daniel Thornburgh, Rainey Booth, Ted Meadows, Chris Kirchmer. Defendants/Corporate Representatives: Lane Heard, Lyn Pruitt, Catherine Corless, Matt Brammer, Christina Gaarder, Jim Julian, Janet Pulliam, Marcela Kirberger, John Borger, Debra O'Gorman, K.C. Green, Emily Hicks, Joe Babington, Jennifer La Mont, Brandon Cate, Brian Troyer, Alan Vickery, Mike Bruyere, Sarah Cullen, Caroline Tinsley. (Court Reporter Cheryl Nelson.) (mmb) |
![]() |
Filing 3170 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc January 23, 2013 Letter from L. Heard to Judge Wilson (Heard, F.) |
Filing 3169 NOTICE of Hearing: Status Conference set for 1/25/2013 09:00 AM in Little Rock, Courtroom # A401 before Judge Billy Roy Wilson.(mmb) |
Filing 3168 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3165 Order Letter from Lane Heard to Judge Wilson (Heard, F.) |
![]() |
Filing 3166 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3165 Order January 4, 2013 Letter from Lane Heard to Judge Wilson (Heard, F.) |
![]() |
![]() |
Filing 3163 NOTICE by Counsel Plaintiff Lead Request for Submission of Common Benefit Time and Expenses to Plaintiffs' Counsel (Millrood, Tobias) |
Filing 3162 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Brooks, Brian) (Docket text modified on 11/19/2012.) (thd). |
NOTICE OF DOCKET CORRECTION re: #3162 Notice of Appeal. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case). (thd) |
![]() |
![]() |
Filing 3159 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Hicks, Emily) (Docket text modified on 11/9/2012.) (thd). |
Filing 3158 DOCUMENT FILED IN ERROR - DISREGARD (wrong case) (Hicks, Emily) (Docket text modified on 11/9/2012.) (thd). |
NOTICE OF DOCKET CORRECTION re: #3158 and #3159 Joint MOTIONS to Dismiss. CORRECTION: The docket text for each entry was modified to indicate the documents were filed in error (wrong case). (thd) |
![]() |
Filing 3156 NOTICE OF DOCKET CORRECTION re: #3155 Order. CORRECTION: The original document contained a typographical error (incorrect year in date); the correct document was added as an attachment to docket entry #3155 and is attached hereto for service on the parties. (thd) |
![]() |
Filing 3154 RESPONSE re #3148 Notice (Other),, Response to Plaintiffs' Notification of Remaining Generic Discovery Against Wyeth and Pfizer Defendants by Wyeth Inc, Wyeth Pharmaceuticals Inc (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Heard, F.) |
![]() |
Filing 3152 BRIEF IN SUPPORT re #3151 Motion for Extension of Time to File Answer filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3151 MOTION for Extension of Time to File Answer re #3134 Order, by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3150 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3149 Notice (Other) October 16, 2012 Letter from Lane Heard to Judge Wilson (Heard, F.) |
Filing 3149 NOTICE by Counsel Plaintiff Lead Letter to Judge Wilson from Zoe Littlepage (Littlepage, Zoe) |
Filing 3148 NOTICE by Counsel Plaintiff Lead Plaintiffs' Notification of Remaining Generic Discovery Against Wyeth and Pfizer Defendants (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19)(Littlepage, Zoe) |
![]() |
REMARK: Receipt of electronic record from USDC ND of TX C.A. No. 3:12-cv-3567 Stephenson v. Wyeth, LLC, et al, (OUR CASE NO. 4:12-cv-620 BRW). (tjj) |
![]() |
Filing 3145 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Malone, Patrick) (Docket text modified on 10/2/2012.) (thd). |
Filing 3144 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Malone, Patrick) (Docket text modified on 10/2/2012.) (thd). |
Filing 3143 CONDITIONAL TRANSFER ORDER (CTO-226) from the Judicial Panel of Multidistrict Litigation that the 1 action listed in this Order now pending in the Northern District of Texas (1) is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 10/2/2012(tjj) |
NOTICE OF DOCKET CORRECTION re: #3145 Amended Complaint. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case). (thd) |
NOTICE OF DOCKET CORRECTION re: #3144 Notice of Appearance of Patrick Malone. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case). (thd) |
Filing 3142 NOTICE by plaintiffs' attorney re #3136 MOTION for Order Motion to De-List PPO-9. Plaintiffs in Sbrocchi v. Wyeth, et al, Case No. 4:06-cv-01195-BRW, have provided defts with documentation establishing authority of the named personal representative in this case. Acordingly, the Sbrocchi case is no longer subject to defts' "de-list" motion. (kpr) |
Filing 3141 RESPONSE in Opposition re #3138 MOTION for Order Plaintiffs' Steering Committee's Renewed Motion for Release of Common Benefit Funds filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3140 RESPONSE to Motion re #3136 MOTION for Order Motion to De-List PPO-9 Plaintiffs filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Remark: Receipt of electronic record from USDC Massachusetts, Case No. 1:12-cv-11660 Ellen Enright et al v. Barr Laboratories Inc., et al (OUR CASE NO. 4:12-cv-00601). (dmn) |
Filing 3139 BRIEF IN SUPPORT re #3138 Motion for Order Plaintiffs' Steering Committee's Renewed Motion for Release of Common Benefit Funds filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
Filing 3138 MOTION for Order Plaintiffs' Steering Committee's Renewed Motion for Release of Common Benefit Funds by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 3137 BRIEF IN SUPPORT re #3136 Motion for Order Memorandum in Support of Motion to De-List PPO-9 Plaintiffs filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3136 MOTION for Order Motion to De-List PPO-9 Plaintiffs by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3135 CONDITIONAL TRANSFER ORDER (CTO-225) from the Judicial Panel of Multidistrict Litigation stating that action 1:12-cv-11660 currently pending in the District of Massachusetts is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 9/20/2012. (dmn) |
![]() |
![]() |
Filing 3132 NOTICE OF DOCKET CORRECTION re: #3130 ORDER: Jury Trial set to commence on 2/4/2013 at 9:00 AM. CORRECTION: The original document contained a typographical error (incorrect year in date); the correct document was added as an attachment to docket entry #3130 and is attached hereto for service on the parties. (thd) |
![]() |
![]() |
Filing 3129 REPLY to Response to Motion re #3117 MOTION for Order Motion to Identify, Justify and Set Deadline for Further Generic Discovery Plaintiffs' Sur-Reply to Defendants' Motion to Identify, Justify and Set Deadline for Further Generic Discovery filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3128 REPLY to Response to Motion re #3117 MOTION for Order Motion to Identify, Justify and Set Deadline for Further Generic Discovery filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
![]() |
Filing 3125 RESPONSE to Motion re #3117 MOTION for Order Motion to Identify, Justify and Set Deadline for Further Generic Discovery filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
![]() |
Filing 3123 Unopposed MOTION for Extension of Time to File Response/Reply as to #3117 MOTION for Order Motion to Identify, Justify and Set Deadline for Further Generic Discovery by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 3122 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 8/16/2012. (dmn) |
Filing 3121 NOTICE by Counsel Plaintiff Lead re Status of PSC (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Williams, Michael) |
Filing 3120 REPLY to Response to Motion re #3100 MOTION for Disbursement of Funds Surreply Re Motion for Release of Common Benefit Funds filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
Filing 3118 BRIEF IN SUPPORT re #3117 Motion for Order Memorandum in Support of Motion to Identify, Justify and Set Deadline for Further Generic Discovery filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3117 MOTION for Order Motion to Identify, Justify and Set Deadline for Further Generic Discovery by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3116 REPLY to Response to Motion re #3100 MOTION for Disbursement of Funds filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
![]() |
![]() |
Filing 3113 SEALED DOCUMENT (tjj) |
![]() |
![]() |
Filing 3110 RESPONSE to Motion re #3108 MOTION to Seal Document #3107 Response in Opposition to Motion Motion for Leave to File Under Seal and Memorandum in Support filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
![]() |
Filing 3108 MOTION to Seal Document #3107 Response in Opposition to Motion Motion for Leave to File Under Seal and Memorandum in Support by Wyeth Inc (Pruitt, Lyn) |
Filing 3107 RESPONSE in Opposition re #3100 MOTION for Disbursement of Funds Opposition to PSC's Motion for Release of Common Benefit Funds filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3106 TRANSCRIPT of Status Conference Proceedings held on 7/20/2012, before Judge Billy R. Wilson. Court Reporter: Eugenie M. Power. Transcript may be viewed only at the public terminals in the Clerk's office. Copies of transcript are only available through the Official Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. DEADLINES: Notice of Intent to Request Redaction due 8/6/2012. Redaction Request due 8/17/2012. Redacted Transcript Deadline set for 8/27/2012. Release of Transcript Restriction set for 10/25/2012. (dmn) |
Filing 3105 BRIEF IN SUPPORT re #3081 Brief in Support, #3080 Motion for Order to Show Cause Supplemental Memorandum in Support of Wyeth's Third Motion to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery From Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3104 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson:Status Conference with parties held on 7/20/2012. Agenda issues addressed by all parties. Pl: Z. Littlepage, R. Booth, L. OLeary, dft: L. Pruitt, G. Geyerman, J. Peck, G. Salenger.(Court Reporter Eugenie Power.) (mmb) |
Filing 3103 NOTICE OF DOCKET CORRECTION re: #3099 RESPONSE in Opposition re #3089 MOTION to Enforce Protective Order and Plaintiffs' Request for Blood Clot Deposition. CORRECTION: The correct main document and Exhibits 4-6 were added as attachments to docket entry #3099 , based on the attached correspondence. (thd) |
Filing 3102 REPLY to Response to Motion re #3087 MOTION for Judgment on the Pleadings , #3082 MOTION for Judgment on the Pleadings Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Myl filed by Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc. (Attachments: #1 Exhibit, #2 Exhibit)(Saelinger, Gina) |
Filing 3101 MEMORANDUM of points and authorities re #3100 Motion for Disbursement of Funds filed by Counsel Plaintiff Lead. (Cloar, Ralph) |
Filing 3100 MOTION for Disbursement of Funds by Counsel Plaintiff Lead (Cloar, Ralph) |
Filing 3099 RESPONSE in Opposition re #3089 MOTION to Enforce Protective Order and Plaintiffs' Request for Blood Clot Deposition filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Littlepage, Zoe) (Additional attachment(s) added on 7/18/2012: #4 Main Document - Correct, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6) (thd). |
Filing 3098 NOTICE by Counsel Plaintiff Lead Plaintiffs' Proposed Agenda for July 20, 2012 Status Conference Hearing (Littlepage, Zoe) |
Filing 3097 AFFIDAVIT in Opposition re #3087 MOTION for Judgment on the Pleadings , #3082 MOTION for Judgment on the Pleadings Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Myl filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 3A, Part 1, #5 Exhibit 3A, Part 2, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10)(Littlepage, Zoe) |
Filing 3096 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3093 Order, Defendants' Agenda for July 20, 2012 Hearing (Heard, F.) |
Filing 3095 RESPONSE in Opposition re #3082 MOTION for Judgment on the Pleadings Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Myl CERTAIN PLAINTIFFS' OPPOSITION TO DEFENDANTS' BARR PHARMACEUTICALS, LLC'S, ET AL. MOTION FOR JUDGEMENT ON THE PLEADINGS filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit Exhibit A)(Calwell, W.) |
Filing 3094 RESPONSE in Opposition re #3087 MOTION for Judgment on the Pleadings , #3082 MOTION for Judgment on the Pleadings Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Myl filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
![]() |
Filing 3092 NOTICE of Appearance by Gina M. Saelinger on behalf of Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc (Saelinger, Gina) |
Filing 3091 REPLY to Response to Motion re #3080 Third MOTION for Order to Show Cause Why the Plaintiffs' Steering Commitee Should Not Petition This Court to Pursue Generic Discovery from Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Heard, F.) |
Filing 3090 BRIEF IN SUPPORT re #3089 Motion to Enforce Protective Order filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3089 MOTION to Enforce Protective Order by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
Filing 3087 MOTION for Judgment on the Pleadings by Galen Holdings PLC, Warner Chilcott (Attachments: #1 Exhibit 1 (Case List))(Cate, Brandon) |
Filing 3086 RESPONSE in Opposition re #3080 Third MOTION for Order to Show Cause Why the Plaintiffs' Steering Commitee Should Not Petition This Court to Pursue Generic Discovery from Wyeth filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24)(Littlepage, Zoe) |
![]() |
REMARK: Receipt of electronic record from USDC of Puerto Rico C.A. No. 3:12-cv-1427, Diaz-Castro v. Wyeth Ayerst Inc., et al (OUR CASE NO. 4:12-cv-377 BRW)(tjj) |
Filing 3084 BRIEF IN SUPPORT re #3064 Motion for Order to Show Cause Supplemental Memorandum in Support of Second Motion to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery From Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3083 BRIEF IN SUPPORT re #3082 Motion for Judgment on the Pleadings,,, Memorandum in Support of Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Mylan Laboratories Inc.); Qualitest Pharmaceuticals, Inc.; Rosemont Pharmaceutical Corporation (n/k/a VCF, Inc.); USL Pharma, Inc./Upsher-Smith Laboratories; Martec Pharmaceuticals, Inc.; Harvard Drug Group; Ortho-McNeil-Janssen Pharmaceuticals, Inc. (f/k/a Ortho-McNeil Pharmaceutical, Inc.); Johnson & Johnson; Watson Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Fielding Pharmaceutical Company; and Novavax, Inc.'s Motion for Judgment on the Pleadings filed by Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc. (Attachments: #1 Exhibit 1 - Appendix A: List of Cases, #2 Exhibit 2 - Exemplar Joint Motions to Dismiss, #3 Exhibit 3 - Appendix of Case Law)(Saelinger, Gina) |
Filing 3082 MOTION for Judgment on the Pleadings Defendants Barr Pharmaceuticals, LLC (f/k/a Barr Pharmaceuticals, Inc.); Barr Laboratories, Inc.; Teva Womens Health, Inc. (f/k/a Duramed Pharmaceuticals, Inc.); Mylan Pharmaceuticals Inc.; Mylan Inc. (f/k/a Mylan Laboratories Inc.); Qualitest Pharmaceuticals, Inc.; Rosemont Pharmaceutical Corporation (n/k/a VCF, Inc.); USL Pharma, Inc./Upsher-Smith Laboratories; Martec Pharmaceuticals, Inc.; Harvard Drug Group; Ortho-McNeil-Janssen Pharmaceuticals, Inc. (f/k/a Ortho-McNeil Pharmaceutical, Inc.); Johnson & Johnson; Watson Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Fielding Pharmaceutical Company; and Novavax, Inc.'s Motion for Judgment on the Pleadings by Barr Laboratories Inc, Barr Pharmaceuticals Inc, Duramed Pharmaceuticals Inc (Attachments: #1 Exhibit 1 - Appendix A: List of Cases)(Saelinger, Gina) |
Filing 3081 BRIEF IN SUPPORT re #3080 Motion for Order to Show Cause Why the Plaintiffs' Steering Commitee Should Not Petition This Court to Pursue Generic Discovery from Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Heard, F.) |
Filing 3080 Third MOTION for Order to Show Cause Why the Plaintiffs' Steering Commitee Should Not Petition This Court to Pursue Generic Discovery from Wyeth by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3079 CONDITIONAL TRANSFER ORDER (CTO-224) from the Judicial Panel of Multidistrict Litigation that the 1 action listed in this Order now pending in the District of Puerto Rico (1) is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 6/18/12. (tjj) |
Filing 3078 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 6/15/12. (tjj) |
![]() |
Filing 3076 MOTION to Withdraw as Attorney Ellen A. Presby's Motion to Withdraw from PSC by Counsel Plaintiff Lead (Presby, Ellen) |
![]() |
Filing 3074 REPLY to Response to Motion re #3066 MOTION to Compel Disclosure of Fees Paid to Plaintiffs' Experts filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
NOTICE OF DOCKET CORRECTION re #3072 Order: docket text modified to correct name of person that signed Order to John G. Heyburn II, Chairman of Multidistrict Litigation Panel. (bfw) |
![]() |
Filing 3071 RESPONSE in Opposition re #3066 MOTION to Compel Disclosure of Fees Paid to Plaintiffs' Experts And/Or In the Alternative, Plaintiffs' Motion to Compel Disclosure of Fees Paid to All Defendants' Experts filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Littlepage, Zoe) |
Filing 3070 REPLY to Response to Motion re #3064 Second MOTION for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3069 RESPONSE in Opposition re #3064 Second MOTION for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
REMARK: Receipt of electronic record from USDC Northern District of Ohio, C.A. No. 5:12-cv-1254 Cline, et al v. Wyeth LLC, et al, (OUR CASE NO. 4:12-cv-340 BRW). (tjj) |
Filing 3068 REPLY to Response to Motion re #3046 MOTION for Order Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses And/Or Plaintiffs' Motion for Leave to Serve Additional Discovery Surreply filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3067 BRIEF IN SUPPORT re #3066 Motion to Compel Disclosure of Fees Paid to Plaintiffs' Experts filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3066 MOTION to Compel Disclosure of Fees Paid to Plaintiffs' Experts by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3065 BRIEF IN SUPPORT re #3064 Motion for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery From Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3064 Second MOTION for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3063 CONDITIONAL TRANSFER ORDER (CTO-223) from the Judicial Panel of Multidistrict Litigation that the 1 action listed in this Order now pending in the Northern District of Ohio (1) is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 6/1/12. (tjj) |
Filing 3062 RESPONSE in Opposition re #3046 MOTION for Order Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses And/Or Plaintiffs' Motion for Leave to Serve Additional Discovery Further Opposition to Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses and/or Plaintiffs' Motion for Leave to Serve Additional Discovery filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3061 REPLY to Response to Motion re #3046 MOTION for Order Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses And/Or Plaintiffs' Motion for Leave to Serve Additional Discovery filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 3060 RESPONSE in Opposition re #3046 MOTION for Order Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses And/Or Plaintiffs' Motion for Leave to Serve Additional Discovery filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Heard, F.) |
![]() |
Filing 3058 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding cases to the transferor courts. Signed by the Clerk of Panel on 5/23/12. (tjj) |
![]() |
Filing 3056 NOTICE OF DOCKET CORRECTION re: #3055 ORDER attached in Exhibit A, cases designated to proceed with case-specific discovery under Practice and Procedure Order 9. CORRECTION: The original document contained a clerical error in the signature date; the correct document was added as an attachment to docket entry #3055 and is attached hereto for service on the parties. (thd) |
![]() |
Filing 3054 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3042 Order Report Re Scheduling of PPO-9 Depositions (Heard, F.) |
![]() |
![]() |
Filing 3051 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding cases to the transferor courts. Signed by the Clerk of Panel on 5/16/12. (tjj) |
Filing 3050 NOTICE OF DOCKET CORRECTION re #3043 MDL Pretrial Order: entry modified to attach document with correct transferor court's case number for Case 4:05-cv-814 in Exhibit A. (copy of correct document attached hereto) (bfw) |
Filing 3047 NOTICE by Counsel Plaintiff Lead Plaintiffs' Notice to Court Re: 30(b)(6) Deposition on Blood Clot Issues (Littlepage, Zoe) |
![]() |
![]() |
Filing 3046 MOTION for Order Plaintiffs' Motion to Enforce the Federal Rules Requiring Supplementation of Prior Discovery Responses And/Or Plaintiffs' Motion for Leave to Serve Additional Discovery by Counsel Plaintiff Lead (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Littlepage, Zoe) |
![]() |
Filing 3044 REPLY re #3031 Notice (Other) Reply in Support of Submission of Violet Armstrong by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
![]() |
Filing 3041 OBJECTIONS by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3024 Order. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 3040 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Stevens, Catherine) (Docket text modified on 5/10/2012.) (thd). |
NOTICE OF DOCKET CORRECTION re: #3040 Notice of Appearance by Catherine Stevens on behalf of Wyeth Inc, Wyeth Pharmaceuticals Inc. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case). (thd) |
Filing 3039 NOTICE by Counsel Plaintiff Lead re #3031 Notice (Other) Plaintiffs' Objection to Wyeth's Request for Submission of Violet Armstrong as New Trial Plaintiff (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Littlepage, Zoe) |
![]() |
Filing 3037 RESPONSE to Motion re #3017 MOTION for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery from Wyeth filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
![]() |
Filing 3035 BRIEF IN SUPPORT re #3017 Motion for Order to Show Cause Supplemental Memorandum in Support of Motion to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court To Pursue Generic Discovery From Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
REMARK: Receipt of electronic record from USDC of MN C.A. No. 0:08-cv-0946 Destefano, et al v. Wyeth, Inc., et al (OUR CASE NO. 4:12-cv-267 BRW).(tjj) |
REMARK: Receipt of electronic record from USDC of MN C.A. No. 0:08-cv-01816 Coulter, et al v. Wyeth, Inc., et al (OUR CASE NO. 4:04-cv-266 BRW).(tjj) |
Filing 3034 CONDITIONAL TRANSFER ORDER (CTO-222) from the Judicial Panel of Multidistrict Litigation that the 2 actions listed in this Order now pending in the District of Minnesota (2) are now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 5/4/12.(tjj) |
Filing 3033 NOTICE OF DOCKET CORRECTION re: #3032 Practice and Procedure Order 10 -- Summary of Rulings. CORRECTION: The original document contained a clerical error; the correct document was added as an attachment to docket entry #3032 and is attached hereto for service on the parties. (thd) |
![]() |
Filing 3031 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2905 Order,, Submission Re Substitution of Trial Plaintiff (Heard, F.) |
![]() |
![]() |
![]() |
![]() |
Filing 3026 BRIEF IN SUPPORT re #3025 Motion to Withdraw as Attorney Memorandum in Support of Erik Walker's Motion to Withdraw from PSC filed by Counsel Plaintiff Lead. (Walker, Erik) |
Filing 3025 MOTION to Withdraw as Attorney Erik Walker's Motion to Withdrawl from PSC by Counsel Plaintiff Lead (Walker, Erik) |
![]() |
Filing 3023 RESPONSE in Opposition re #3008 MOTION for Order Motion to Amend Supplemental Order re Ex Parte Interviews Plaintiffs' Opposition to Wyeth's Motion to Amend Supplemental Order re Ex Parte Interviews filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Walker, Erik) |
![]() |
Filing 3021 REPLY to Response to Motion re #2984 MOTION for Order to Supplement Stay Order filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3020 NOTICE by Counsel Plaintiff Lead Plaintiffs' Proposed Agenda for April 27, 2012 Status Conference (Walker, Erik) |
Filing 3019 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #3013 Order, Set Scheduling Order Deadlines,, Defendants' Agenda for April 27, 2012 Hearing (Heard, F.) |
Filing 3018 BRIEF IN SUPPORT re #3017 Motion for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery from Wyeth filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Heard, F.) |
Filing 3017 MOTION for Order to Show Cause Why the Plaintiffs' Steering Committee Should Not Petition This Court to Pursue Generic Discovery from Wyeth by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
![]() |
Filing 3014 REPLY to Response to Motion re #3010 MOTION to Enforce Deposition Disclosure Agreement filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
![]() |
Filing 3012 RESPONSE in Opposition re #3010 MOTION to Enforce Deposition Disclosure Agreement filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Littlepage, Zoe) |
Filing 3011 BRIEF IN SUPPORT re #3010 Motion to Enforce Deposition Disclosure Agreement filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Heard, F.) |
Filing 3010 MOTION to Enforce Deposition Disclosure Agreement by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 3009 BRIEF IN SUPPORT re #3008 Motion for Order Memorandum in Support of Motion to Amend Supplemental Order Re Ex Parte Interviews filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 3008 MOTION for Order Motion to Amend Supplemental Order re Ex Parte Interviews by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
![]() |
NOTICE OF DOCKET CORRECTION re #3006 Order on Motion to Exclude: docket text modified to add the motion document numbers and to read as: "ORDER denying #2700 #2707 #2709 #2715 Motions to Exclude Testimony re: (ER+/PR-)." (bfw) |
![]() |
![]() |
Filing 3003 RESPONSE in Opposition re #2705 MOTION to Exclude ANY GENERAL AND SPECIFIC CAUSATION OPINION THAT PREMPRO CAUSES ESTROGEN-RECEPTOR-POSITIVE / HER2-POSITIVE (ER+/HER2+) BREAST CANCER Plaintiffs' Response in Opposition to Defendants' Supplemental Memorandum filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55)(Littlepage, Zoe) |
Filing 3002 NOTICE by Pfizer Inc, Pharmacia & Upjohn Company, Pharmacia Company, Pharmacia Corporation, Wyeth Inc, Wyeth Pharmaceuticals Inc re #27 Order,, Undertaking Pursuant to Confidentiality Order for Catherine A. Mohan (Heard, F.) |
Filing 3001 MEMORANDUM re #2705 MOTION to Exclude ANY GENERAL AND SPECIFIC CAUSATION OPINION THAT PREMPRO CAUSES ESTROGEN-RECEPTOR-POSITIVE / HER2-POSITIVE (ER+/HER2+) BREAST CANCER filed by Wyeth Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55, #56 Exhibit 56, #57 Exhibit 57, #58 Exhibit 58, #59 Exhibit 59, #60 Exhibit 60, #61 Exhibit 61, #62 Exhibit 62, #63 Exhibit 63, #64 Exhibit 64, #65 Exhibit 65, #66 Document 66, #67 Document 67, #68 Exhibit 68, #69 Exhibit 69, #70 Exhibit 70, #71 Exhibit 71)(Heard, F.) |
Filing 3000 RESPONSE in Opposition re #2705 MOTION to Exclude ANY GENERAL AND SPECIFIC CAUSATION OPINION THAT PREMPRO CAUSES ESTROGEN-RECEPTOR-POSITIVE / HER2-POSITIVE (ER+/HER2+) BREAST CANCER Plaintiffs' Supplemental Brief filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32)(Littlepage, Zoe) |
Filing 2999 REPLY to Response to Motion re #2955 MOTION for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) Reply to Plaintiffs' Supplemental Opposition to Motion for Protective Order Re Plaintiffs' Notice of Corporate Representative of Defendant Wyeth Pursuant to Rule 30(b)(6) filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2998 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #27 Order,, Undertaking Pursuant to Confidentiality Order for Joseph D. Cohen (Heard, F.) |
Filing 2997 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 4/2/12. (tjj) |
Filing 2996 RESPONSE in Opposition re #2984 MOTION for Order to Supplement Stay Order Plaintiffs' Opposition to Motion to Supplement Stay Order filed by Counsel Plaintiff Lead. (Walker, Erik) |
Filing 2995 RESPONSE in Opposition re #2955 MOTION for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) SUPPLEMENTAL RESPONSE filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 2994 NOTICE of Appearance by Emily J. Hicks on behalf of Mylan Laboratories Inc (Hicks, Emily) |
Filing 2993 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 3/26/12. (tjj) |
![]() |
Filing 2991 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2959 Order,, Wyeths Submission re February 29, 2012 Order (Attachments: #1 Exhibit A, #2 Exhibit B)(Heard, F.) |
![]() |
Filing 2989 RESPONSE in Opposition re #2979 MOTION for Protective Order Re 730 Deposition Notices filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9)(Littlepage, Zoe) |
![]() |
Filing 2987 RESPONSE re #2905 Order,, #2978 Notice (Other) Plaintiff's Opposition to Submission re Order [Doc. No. 2905] by Counsel Plaintiff Lead (Walker, Erik) |
Filing 2986 REPLY to Response to Motion re #2955 MOTION for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2985 BRIEF IN SUPPORT re #2984 Motion for Order to Supplement Stay Order filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2984 MOTION for Order to Supplement Stay Order by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2983 RESPONSE in Opposition re #2955 MOTION for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) filed by Counsel Plaintiff Lead. (Walker, Erik) |
Filing 2982 REPLY to Response to Motion re #2948 MOTION to Strike the Expert Report of Dr. John Sunyecz on Oral Micronized Progesterone As a Safer Alternative to MPA filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
Filing 2980 BRIEF IN SUPPORT re #2979 Motion for Protective Order Re 730 Deposition Notices filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2979 MOTION for Protective Order Re 730 Deposition Notices by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2978 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2905 Order,, Submission Re Order (Heard, F.) |
Filing 2977 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding case to the transferor court. Signed by the Clerk of Panel on 3/9/12. (tjj) |
Filing 2976 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2961 Order, Submission Re Case Status (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 2975 RESPONSE in Opposition re #2948 MOTION to Strike the Expert Report of Dr. John Sunyecz on Oral Micronized Progesterone As a Safer Alternative to MPA Plaintiffs' Opposition to Motion to Strike the Expert Report of Dr. John Sunyecz on Oral Micronized Progesterone As A Safer Alternative to MPA filed by Counsel Plaintiff Lead. (Walker, Erik) |
Filing 2974 NOTICE OF DOCKET CORRECTION re #2973 Order on Motion for Protective Order: entry modified to attach corrected pdf due to typo in the footnote of original document. (correct document attached hereto) (bfw) |
![]() |
Filing 2972 RESPONSE in Opposition re #2968 MOTION for Protective Order Re Deposition of Dr. Gadi Plaintiff's Opposition to Motion for Protective Order Re: Deposition of Dr. Gadi filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Walker, Erik) |
Filing 2971 CORRECTED CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding cases to the transferor courts. Signed by the Clerk of Panel on 3/7/2012. (thd) |
Filing 2970 CONDITIONAL REMAND ORDER from the Judicial Panel on Multidistrict Litigation (Panel) remanding cases to the transferor courts. Signed by the Clerk of Panel on 3/6/2012. (thd) (Docket text modified on 3/8/2012 to correct typographical error.) (thd). |
Filing 2969 BRIEF IN SUPPORT re #2968 Motion for Protective Order Re Deposition of Dr. Gadi filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2968 MOTION for Protective Order Re Deposition of Dr. Gadi by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2967 NOTICE of Attorney's Special Charging Lien filed by Paul H Crouch. (kjp) |
Filing 2966 NOTICE by Counsel Plaintiff Lead re #2959 Order,, Plaintiff's Submission RE 2/29/2012 Order on Deposition Scheduling (Aylstock, Bryan) |
Filing 2965 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc Wyeth's Submission Re February 29, 2012 Order on Deposition Scheduling (Heard, F.) |
![]() |
Filing 2963 NOTICE by Counsel Plaintiff Lead re #2959 Order,, Plaintiff's Submission RE: February 29, 2012 Order on Deposition Scheduling (Walker, Erik) |
Filing 2962 REPLY to Response to Motion re #2872 MOTION to Exclude Any Expert Testimony That Prepro Can Cause Lobular Breast Cancer With Approximately Three Years or Less of Use filed by Wyeth Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22)(Heard, F.) |
![]() |
![]() |
![]() |
Filing 2958 REPLY re #2939 Notice (Other) Wyeth's Correction of Plaintiffs' Filing Re Plaintiffs in PPO-9, Wave 5 Who Are Ready for Remand by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Heard, F.) |
![]() |
Filing 2956 BRIEF IN SUPPORT re #2955 Motion for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Heard, F.) |
Filing 2955 MOTION for Protective Order Re Plaintiffs' Notice of Corporate Deposition of Defendant Wyeth Pursuant to Rule 30(b)(6) by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
![]() |
Filing 2952 RESPONSE in Opposition re #2943 MOTION to Compel Wyeth to Produce Dr. Jorge Reis-Filho for Deposition or in the alternative Motion to Strike Dr. Reis-Filho's Declaration filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Heard, F.) |
Filing 2951 NOTICE by Counsel Plaintiff Lead re #2943 MOTION to Compel Wyeth to Produce Dr. Jorge Reis-Filho for Deposition or in the alternative Motion to Strike Dr. Reis-Filho's Declaration Supplement to Plaintiff's Motion to Compel Wyeth to Produce Dr. Jorge Reis-Filho for Deposition or in the alternative Motion to Strike Dr. Reis-Filho's Declaration (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Walker, Erik) |
Filing 2949 BRIEF IN SUPPORT re #2948 Motion to Strike the Expert Report of Dr. John Sunyecz on Oral Micronized Progesterone As a Safer Alternative to MPA filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2948 MOTION to Strike the Expert Report of Dr. John Sunyecz on Oral Micronized Progesterone As a Safer Alternative to MPA by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2947 TRANSCRIPT of Daubert Proceedings, Volume 2 held on February 15, 2012, before Judge Billy R. Wilson. Court Reporters Karen Baker, Christa R. Newburg, Eugenie M. Power and Judith A. Ammons. Transcript may be viewed only at the public terminals in the Clerk's office. Copies of transcript are only available through the Official Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. DEADLINES: Notice of Intent to Request Redaction due 3/5/2012. Redaction Request due 3/14/2012. Redacted Transcript Deadline set for 3/26/2012. Release of Transcript Restriction set for 5/22/2012. (plm) |
Filing 2946 TRANSCRIPT of Daubert Hearing Proceedings held on February 14, 2012, before Judge Billy R. Wilson. Court Reporters Eugenie M. Power, Karen Baker, Elaine Hinson and Judith A. Ammons. Transcript may be viewed only at the public terminals in the Clerk's office. Copies of transcript are only available through the Official Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. DEADLINES: Notice of Intent to Request Redaction due 3/5/2012. Redaction Request due 3/14/2012. Redacted Transcript Deadline set for 3/26/2012. Release of Transcript Restriction set for 5/22/2012. (plm) |
Filing 2945 REPLY to Response to Motion re #2867 MOTION to Strike Motion to Bar Testimony of Drs. Austin, Gann and Tilley Re Design Defect filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9)(Heard, F.) |
Filing 2944 BRIEF IN SUPPORT re #2943 Motion to Compel Wyeth to Produce Dr. Jorge Reis-Filho for Deposition or in the alternative Motion to Strike Dr. Reis-Filho's Declaration filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Walker, Erik) |
Filing 2943 MOTION to Compel Wyeth to Produce Dr. Jorge Reis-Filho for Deposition or in the alternative Motion to Strike Dr. Reis-Filho's Declaration by Counsel Plaintiff Lead (Walker, Erik) |
Filing 2942 NOTICE of Appearance by Catherine M. Corless on behalf of Pfizer Inc, Wyeth Inc, Wyeth Pharmaceuticals Inc (Corless, Catherine) |
Filing 2941 NOTICE OF DOCKET CORRECTION re #2940 Order: entry modified to attach document with correct transferor court name and number for Case 4:05-cv-676 in Exhibit A. (copy of correct document attached hereto) (bfw) |
![]() |
Filing 2939 NOTICE by Counsel Plaintiff Lead Plaintiffs' Filing Re: Plaintiffs in PPO-9, Wave 5 Who Are Ready for Remand (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Littlepage, Zoe) |
![]() |
Filing 2937 NOTICE by Counsel Plaintiff Lead Plaintiffs' Submission Re: Exhibits From The Cross-Examination of Dr. Kurt Barnhart at Her2 Daubert Hearing (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14)(Littlepage, Zoe) |
Filing 2936 NOTICE OF DOCKET CORRECTION re #2933 MOTION for Extension of Time to File Reply: entry modified to attach the correct document. (copy attached hereto for service on parties) (bfw) |
Filing 2935 RESPONSE re #2910 Order, Plaintiff's Response to Letter Order re: Viability of Claims Against Generic Manufacturers in Light of Mensing v. Wyeth by Counsel Plaintiff Lead (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2, #3 Exhibit Exhibit 3, #4 Exhibit Exhibit 4)(Walker, Erik) |
Filing 2934 NOTICE by Counsel Plaintiff Lead Plaintiffs' Submission Re: Exhibits From the Cross Examination of Dr. Lewis Chodosh at Her2 Daubert Hearing (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12)(Littlepage, Zoe) |
Filing 2933 MOTION for Extension of Time to File Response/Reply as to #2900 Response in Opposition to Motion by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) (Additional attachment added on 2/21/2012: #1 Correct Main Document (bfw). |
Filing 2932 NOTICE by Counsel Plaintiff Lead re 2927 Order on Motion for Extension of Time to File Response/Reply,, Letter re: Court's Order of February 16, 2012 granting plaintiff's motion for extension of time (Walker, Erik) |
Filing 2931 NOTICE by Counsel Plaintiff Lead Filing Re: Cases Eligible for Remand from PPO-9, Wave 5 (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
![]() |
NOTICE OF DOCKET CORRECTION re 2925 Motion Hearing: docket text modified to correct date court recessed until to "2/15/12". (bfw) |
![]() |
![]() |
Filing 2926 MOTION for Extension of Time to File Response/Reply as to #2910 Order, Plaintiffs' Unopposed Motion for Enlargement of Time to Respond to Court's Inquiry: Re: Generic Drug Manufacturers' Claim of Preemption Under Pliva, Inc. v. Mensing by Counsel Plaintiff Lead (Walker, Erik) |
Filing 2929 Minute Entry for proceedings held before Judge Billy Roy Wilson: Motion Hearing continues on 2/15/2012 in re: MOTIONS to Exclude ANY GENERAL AND SPECIFIC CAUSATION OPINION THAT PREMPRO CAUSES ESTROGEN-RECEPTOR-POSITIVE/HER2-POSITIVE (ER+/HER2+) BREAST CANCER. Court adjourns at 5:02 and exhibits are retained by the court. Z Littlepage, R. Booth & E. Walker pltf counsel, C. Campbell, L. Brown, L. Pruitt and L. Heard deft counsel. (Court Reporters Karen Baker, Christa Newburg, Genie Power and Judith A. Ammons) (plm) |
![]() |
Filing 2923 MOTION for Extension of Time to File Response/Reply Re Design Defect by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2921 NOTICE by Counsel Plaintiff Lead PLAINTIFFS SUBMISSION RE: EXHIBITS FOR THE TESTIMONY OF DR. V.K. GADI AT HER2 DAUBERT HEARING (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18)(Littlepage, Zoe) |
Filing 2925 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson: Motion Hearing held on 2/14/2012 re #2713 #2717 #2705 #2711 MOTION to Exclude ANY GENERAL AND SPECIFIC CAUSATION OPINION THAT PREMPRO CAUSES ESTROGEN-RECEPTOR-POSITIVE/HER2-POSITIVE (ER+/HER2+) BREAST CANCER IN ARMSTRONG V. WYETH filed by Wyeth Inc. Evidence and exhibits were entered, court recesses until 2/15/2012. Z. Littlepage, R. Booth & E. Walker pltf counsel, C. Campbell, L. Brown, L. Pruitt and L. Heard deft counsel (Court Reporter Eugenie M. Power, Kaen Baker, Elaine Hinson and Judith A. Ammons.) (plm) (docket text modified on 2/17/2012 to correct date court recessed until to "2/15/12") (bfw). |
Filing 2920 NOTICE by Counsel Plaintiff Lead PLAINTIFFS SUBMISSION RE: EXHIBITS FOR THE TESTIMONY OF DR. PAUL MICHAELS AT HER2 DAUBERT HEARING (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41)(Littlepage, Zoe) |
Filing 2919 NOTICE by Counsel Plaintiff Lead Plaintiffs' Submission Re: Slides Used During Opening Statements at Her2 Daubert Hearing (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
![]() |
Filing 2917 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2916 Reply (Non Motion), Reply (Non Motion), Reply (Non Motion) February 10, 2012 Letter from Lane Heard to Judge Wilson (Heard, F.) |
Filing 2916 REPLY re #2897 Response (Non Motion) Plaintiff's Reply to Wyeth's Response to January 20, 2012 Order Re: Obesity Daubert Hearing by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 1A, #3 Exhibit 1B, #4 Exhibit 1C, #5 Exhibit 1D, #6 Exhibit 1E, #7 Exhibit 1F, #8 Exhibit 1G, #9 Exhibit 1H, #10 Exhibit 1I, #11 Exhibit 1J, #12 Exhibit 1K, #13 Exhibit 2, #14 Exhibit 3, #15 Exhibit 4, #16 Exhibit 5, #17 Exhibit 6, #18 Exhibit 7, #19 Exhibit 8, #20 Exhibit 9, #21 Exhibit 10, #22 Exhibit 11)(Walker, Erik) |
Filing 2915 ADDENDUM filed by Counsel Plaintiff Lead to #2912 Response in Opposition to Motion,,,,. Addendum 3 (Attachments: #1 Exhibit 151, #2 Exhibit 152, #3 Exhibit 153, #4 Exhibit 154, #5 Exhibit 155, #6 Exhibit 156, #7 Exhibit 157, #8 Exhibit 158, #9 Exhibit 159, #10 Exhibit 160, #11 Exhibit 161, #12 Exhibit 162, #13 Exhibit 163, #14 Exhibit 164, #15 Exhibit 165, #16 Exhibit 166, #17 Exhibit 167, #18 Exhibit 168, #19 Exhibit 169, #20 Exhibit 170, #21 Exhibit 171, #22 Exhibit 172, #23 Exhibit 173, #24 Exhibit 174, #25 Exhibit 175, #26 Exhibit 176, #27 Exhibit 177, #28 Exhibit 178, #29 Exhibit 179, #30 Exhibit 180, #31 Exhibit 182, #32 Exhibit 183, #33 Exhibit 184, #34 Exhibit 185, #35 Exhibit 186, #36 Exhibit 187, #37 Exhibit 188, #38 Exhibit 189, #39 Exhibit 190, #40 Exhibit 191, #41 Exhibit 192, #42 Exhibit 193, #43 Exhibit 194, #44 Exhibit 195, #45 Exhibit 196, #46 Exhibit 197, #47 Exhibit 198, #48 Exhibit 199, #49 Exhibit 200, #50 Exhibit 201, #51 Exhibit 202, #52 Exhibit 203, #53 Exhibit 204, #54 Exhibit 205)(Littlepage, Zoe) |
Filing 2914 ADDENDUM filed by Counsel Plaintiff Lead to #2912 Response in Opposition to Motion,,,,. Addendum 2 (Attachments: #1 Exhibit 101, #2 Exhibit 102, #3 Exhibit 103, #4 Exhibit 104, #5 Exhibit 105, #6 Exhibit 106, #7 Exhibit 107, #8 Exhibit 108, #9 Exhibit 109, #10 Exhibit 110, #11 Exhibit 111, #12 Exhibit 112, #13 Exhibit 113, #14 Exhibit 114, #15 Exhibit 115, #16 Exhibit 116, #17 Exhibit 117, #18 Exhibit 118, #19 Exhibit 119, #20 Exhibit 120, #21 Exhibit 121, #22 Exhibit 122, #23 Exhibit 123, #24 Exhibit 124, #25 Exhibit 125, #26 Exhibit 126, #27 Exhibit 127, #28 Exhibit 128, #29 Exhibit 129, #30 Exhibit 130, #31 Exhibit 131, #32 Exhibit 132, #33 Exhibit 133, #34 Exhibit 134, #35 Exhibit 135, #36 Exhibit 136, #37 Exhibit 137, #38 Exhibit 138, #39 Exhibit 139, #40 Exhibit 140, #41 Exhibit 141, #42 Exhibit 142, #43 Exhibit 143, #44 Exhibit 144, #45 Exhibit 145, #46 Exhibit 146, #47 Exhibit 147, #48 Exhibit 148, #49 Exhibit 149, #50 Exhibit 150)(Littlepage, Zoe) |
Filing 2913 ADDENDUM filed by Counsel Plaintiff Lead to #2912 Response in Opposition to Motion,,,,. Addendum 1 (Attachments: #1 Exhibit 51, #2 Exhibit 52, #3 Exhibit 53, #4 Exhibit 54, #5 Exhibit 55, #6 Exhibit 56, #7 Exhibit 57, #8 Exhibit 58, #9 Exhibit 59, #10 Exhibit 60, #11 Exhibit 61, #12 Exhibit 62, #13 Exhibit 63, #14 Exhibit 64, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 67, #18 Exhibit 68, #19 Exhibit 69, #20 Exhibit 70, #21 Exhibit 71, #22 Exhibit 72, #23 Exhibit 73, #24 Exhibit 74, #25 Exhibit 75, #26 Exhibit 76, #27 Exhibit 77, #28 Exhibit 78, #29 Exhibit 79, #30 Exhibit 80, #31 Exhibit 81, #32 Exhibit 82, #33 Exhibit 83, #34 Exhibit 84, #35 Exhibit 85, #36 Exhibit 86, #37 Exhibit 87, #38 Exhibit 88, #39 Exhibit 89, #40 Exhibit 90, #41 Exhibit 91, #42 Exhibit 92, #43 Exhibit 93, #44 Exhibit 94, #45 Exhibit 95, #46 Exhibit 96, #47 Exhibit 97, #48 Exhibit 98, #49 Exhibit 99, #50 Exhibit 100)(Littlepage, Zoe) |
Filing 2912 RESPONSE in Opposition re #2872 MOTION to Exclude Any Expert Testimony That Prepro Can Cause Lobular Breast Cancer With Approximately Three Years or Less of Use filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50)(Littlepage, Zoe) |
Filing 2911 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc February 10, 2012 Letter from Lane Heard to Judge Wilson (Heard, F.) |
![]() |
Filing 2909 NOTICE by Counsel Plaintiff Lead of Her2Neu Daubert Hearing Experts (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Littlepage, Zoe) |
![]() |
Filing 2907 NOTICE by Counsel Plaintiff Lead Correspondence re: Obesity Daubert Hearing (Walker, Erik) |
Filing 2922 SEALED DOCUMENT (tjj) |
Filing 2906 NOTICE OF DOCKET CORRECTION re #2905 Order: the docket text was modified to correct trial dates; and corrected document attached with the trial date of December 5, 2012. (copy of correct document attached hereto)(bfw) |
![]() |
Filing 2904 ADDENDUM filed by Counsel Plaintiff Liaison to #2901 Declaration,,,. (Attachments: #1 Exhibit 76, #2 Exhibit 77, #3 Exhibit 78, #4 Exhibit 79, #5 Exhibit 80, #6 Exhibit 81, #7 Exhibit 82, #8 Exhibit 83, #9 Exhibit 84, #10 Exhibit 85, #11 Exhibit 86, #12 Exhibit 87, #13 Exhibit 88, #14 Exhibit 89, #15 Exhibit 90, #16 Exhibit 91, #17 Exhibit 92, #18 Exhibit 93 - Filed Under Seal, #19 Exhibit 94 - Filed Under Seal, #20 Exhibit 95, #21 Exhibit 96, #22 Exhibit 97, #23 Exhibit 98, #24 Exhibit 99, #25 Exhibit 100)(Williams, Michael) |
Filing 2903 ADDENDUM filed by Counsel Plaintiff Liaison to #2901 Declaration,,,. (Attachments: #1 Exhibit 51, #2 Exhibit 52, #3 Exhibit 53, #4 Exhibit 54, #5 Exhibit 55, #6 Exhibit 56, #7 Exhibit 57, #8 Exhibit 58, #9 Exhibit 59, #10 Exhibit 60, #11 Exhibit 61, #12 Exhibit 62, #13 Exhibit 63, #14 Exhibit 64, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 67, #18 Exhibit 68, #19 Exhibit 69, #20 Exhibit 70, #21 Exhibit 71, #22 Exhibit 72, #23 Exhibit 73, #24 Exhibit 74, #25 Exhibit 75)(Williams, Michael) |
Filing 2902 ADDENDUM filed by Counsel Plaintiff Liaison to #2901 Declaration,,,. (Attachments: #1 Exhibit 26, #2 Exhibit 27, #3 Exhibit 28, #4 Exhibit 29, #5 Exhibit 30, #6 Exhibit 31, #7 Exhibit 32, #8 Exhibit 33, #9 Exhibit 34, #10 Exhibit 35, #11 Exhibit 36, #12 Exhibit 37, #13 Exhibit 38, #14 Exhibit 39, #15 Exhibit 40, #16 Exhibit 41, #17 Exhibit 42, #18 Exhibit 43, #19 Exhibit 44, #20 Exhibit 45, #21 Exhibit 46, #22 Exhibit 47, #23 Exhibit 48, #24 Exhibit 49, #25 Exhibit 52)(Williams, Michael) |
Filing 2901 DECLARATION of Michael L. Williams in Support of Plaintiffs' in Opposition to Motion to Bar Testimony of Drs. Austin, Gann and Tilley Re Design Defect by Counsel Plaintiff Liaison. re #2900 Response in Opposition to Motion filed by Counsel Plaintiff Liaison. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25 - Filed Under Seal)(Williams, Michael) |
Filing 2900 RESPONSE in Opposition re #2867 MOTION to Strike Motion to Bar Testimony of Drs. Austin, Gann and Tilley Re Design Defect filed by Counsel Plaintiff Liaison. (Williams, Michael) |
Filing 2899 STATUS REPORT Re Small Defendants by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 2898 STATUS REPORT Joint Submission of Non-Wyeth Defendants Regarding the Status of Discovery as to the Non-Wyeth Defendants by Ortho McNeil Pharmaceutical Inc. (O'Gorman, Debra) |
Filing 2897 RESPONSE re #2890 Order on Motion for Relief, Order on Motion to Remand,, Order on Motion for Reconsideration,,,,,,,,,,,,,,,, Wyeth's Response to January 20, 2012 Order by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
![]() |
Filing 2894 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc February 2, 2012 Letter from Lane Heard to Judge Wilson (Heard, F.) |
NOTICE OF DOCKET CORRECTION re: #2893 Notice of Change of Address. CORRECTION: The docket text was modified to indicate the document was filed in error (wrong case). (thd) |
Filing 2893 DOCUMENT FILED IN ERROR - DISREGARD (wrong case). (Palmer, Lance) (Docket text modified on 2/2/2012.) (thd). |
Filing 2896 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) Minute Entry for proceedings held before Judge Billy Roy Wilson: Telephone Conference held on 1/27/2012 regarding Daubert Hearing witnesses. Briefs will be submitted. (Court Reporter Karen Baker.) (plm) |
Filing 2892 NOTICE by Wyeth Inc Notice of Live Witnesses for the HER2 Daubert Hearing (Heard, F.) |
Filing 2891 NOTICE by Counsel Plaintiff Lead Live Witnesses for Her2 Hearing (Littlepage, Zoe) |
![]() |
Filing 2889 NOTICE by Counsel Plaintiff Lead Letter to Judge Wilson re HER2-neu Daubert Hearing (Walker, Erik) |
Filing 2888 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2883 Notice (Other) January 19, 2012 Letter from Lane Heard to Judge Wilson (Heard, F.) |
![]() |
![]() |
Filing 2885 RESPONSE in Support re #2876 MOTION to Compel Disclosure of Witnesses and Attendance of Dr. Elizabeth Naftalis at the HER2 Daubert Hearing Supplemental Memorandum in Support of Motion to Compel Disclosure of Witnesses and Attendance of Dr. Elizabeth Naftalis at the HER2 Daubert Hearing filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 2884 RESPONSE in Opposition re #2880 MOTION for Order to Compel Attendance of Dr. Geza Acs at the Her2 Daubert Hearing filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 2883 NOTICE by Counsel Plaintiff Lead Letter to Judge Wilson re: expert witnesses (Walker, Erik) |
![]() |
Filing 2881 BRIEF IN SUPPORT re #2880 Motion for Order to Compel the Attendance of Dr. Geza Acs at the Her2 Daubert Hearing filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
Filing 2880 MOTION for Order to Compel Attendance of Dr. Geza Acs at the Her2 Daubert Hearing by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 2879 BRIEF IN SUPPORT re #2878 Motion to Remand PPO-9 Wave 5 Cases filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
Filing 2878 Amended MOTION to Remand PPO-9 Wave 5 Cases by Counsel Plaintiff Lead (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
Filing 2877 BRIEF IN SUPPORT re #2876 Motion to Compel Disclosure of Witnesses and Attendance of Dr. Elizabeth Naftalis at the HER2 Daubert Hearing filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10)(Heard, F.) |
Filing 2876 MOTION to Compel Disclosure of Witnesses and Attendance of Dr. Elizabeth Naftalis at the HER2 Daubert Hearing by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2875 REPLY to Response to Motion re #2869 MOTION for Reconsideration of Motion to Bar All Testimony of Dr. Bruce Patsner Reply re Motion for Reconsideration of Motion to Bar All Testimony of Dr. Bruce Patsner filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2874 BRIEF IN SUPPORT re #2873 Brief in Support,,, of Motion to Exclude Any Testimony That Prempro Can Cause Lobular Breast Cancer With Approximately Three Years or Less of Use filed by Wyeth Inc. (Attachments: #1 Exhibit 32, #2 Exhibit 33, #3 Exhibit 34, #4 Exhibit 35, #5 Exhibit 36, #6 Exhibit 37, #7 Exhibit 38, #8 Exhibit 39, #9 Exhibit 40, #10 Exhibit 41, #11 Exhibit 42, #12 Exhibit 43, #13 Exhibit 44, #14 Exhibit 45, #15 Exhibit 46, #16 Exhibit 47, #17 Exhibit 48, #18 Exhibit 49, #19 Exhibit 50, #20 Exhibit 51, #21 Exhibit 52, #22 Exhibit 53, #23 Exhibit 54, #24 Exhibit 55, #25 Exhibit 56, #26 Exhibit 57, #27 Exhibit 58, #28 Exhibit 59, #29 Exhibit 60, #30 Exhibit 61, #31 Exhibit 62, #32 Exhibit 63, #33 Exhibit 64, #34 Exhibit 65, #35 Exhibit 66, #36 Exhibit 67, #37 Exhibit 68, #38 Exhibit 69, #39 Exhibit 70, #40 Exhibit 71, #41 Exhibit 72, #42 Exhibit 73, #43 Exhibit 74, #44 Exhibit 75, #45 Exhibit 76, #46 Exhibit 77, #47 Exhibit 78, #48 Exhibit 79, #49 Exhibit 80, #50 Exhibit 81, #51 Exhibit 82, #52 Exhibit 83, #53 Exhibit 84, #54 Exhibit 85, #55 Exhibit 86, #56 Exhibit 87, #57 Exhibit 88, #58 Exhibit 89, #59 Exhibit 90, #60 Exhibit 91, #61 Exhibit 92, #62 Exhibit 93, #63 Exhibit 94, #64 Exhibit 95, #65 Exhibit 96, #66 Exhibit 97, #67 Exhibit 98, #68 Exhibit 99, #69 Exhibit 100, #70 Exhibit 101, #71 Exhibit 102, #72 Exhibit 103, #73 Exhibit 104, #74 Exhibit 105, #75 Exhibit 106, #76 Exhibit 107, #77 Exhibit 108, #78 Exhibit 109, #79 Exhibit 110, #80 Exhibit 111, #81 Exhibit 112, #82 Exhibit 113, #83 Exhibit 114, #84 Exhibit 115, #85 Exhibit 116)(Heard, F.) |
Filing 2873 BRIEF IN SUPPORT re #2872 Motion to Exclude Any Expert Testimony That Prempro Can Cause Lobular Breast Cancer With Approximately Three Years or Less of Use filed by Wyeth Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31 part 1, #32 Exhibit 31 part 2)(Heard, F.) |
Filing 2872 MOTION to Exclude Any Expert Testimony That Prepro Can Cause Lobular Breast Cancer With Approximately Three Years or Less of Use by Wyeth Inc (Heard, F.) |
Filing 2871 RESPONSE in Opposition re #2869 MOTION for Reconsideration of Motion to Bar All Testimony of Dr. Bruce Patsner filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 3)(Littlepage, Zoe) |
Filing 2870 BRIEF IN SUPPORT re #2869 Motion for Reconsideration Memorandum in Support of Motion for Reconsideration of Motion to Bar All Testimony of Dr. Bruce Patsner filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2869 MOTION for Reconsideration of Motion to Bar All Testimony of Dr. Bruce Patsner by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2868 BRIEF IN SUPPORT re #2867 Motion to Strike Memorandum in Support of Motion to Bar Testimony of Drs. Austin, Gann and Tilley Re Design Defect filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22)(Heard, F.) |
Filing 2867 MOTION to Strike Motion to Bar Testimony of Drs. Austin, Gann and Tilley Re Design Defect by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
REMARK: Receipt of electronic record from USDC Northern District of Illinois, 1:11-cv-8228, Pesch v. Wyeth, et al (OUR CASE NO. 4:11-cv-898 BRW). (tjj) |
![]() |
Filing 2865 CONDITIONAL TRANSFER ORDER (CTO-221) from the Judicial Panel of Multidistrict Litigation that the 1 action listed in this Order now pending in the Northern District of Illinois (1) is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 12/14/11.(tjj) |
Filing 2864 ADDENDUM filed by Counsel Plaintiff Lead to #2863 Response in Opposition to Motion,,,. (Attachments: #1 Exhibit 41, #2 Exhibit 42, #3 Exhibit 43, #4 Exhibit 44, #5 Exhibit 45, #6 Exhibit 46, #7 Exhibit 47, #8 Exhibit 48, #9 Exhibit 49, #10 Exhibit 50, #11 Exhibit 51, #12 Exhibit 52, #13 Exhibit 53, #14 Exhibit 54, #15 Exhibit 55)(Littlepage, Zoe) |
Filing 2863 RESPONSE in Opposition re #2834 MOTION for Order Motion to Bar All Testimony of Dr. Bruce Patsner filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40)(Littlepage, Zoe) |
![]() |
NOTICE OF DOCKET CORRECTION re: #2856 Order. CORRECTION: The docket entry was modified to establish linkage to #2808 defts' motion to compel or, in the alternative, strike Dr. Colditz's expert designation and report. (thd) |
Filing 2861 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2858 Order December 12, 2011 Letter from Lane Heard to Judge Wilson (Heard, F.) |
Filing 2860 NOTICE by Counsel Plaintiff Lead Joint Submission Re MDL Cases that are Short-Term Use, Her2Neu Positive, Or Progesterone Receptor Negative (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
![]() |
![]() |
![]() |
Filing 2855 RESPONSE to Motion re #2853 MOTION for Order Motion for Revision of Schedule re Daubert Challenge Concerning Short-Term Use and Lobular Cancer filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 2854 BRIEF IN SUPPORT re #2853 Motion for Order Memorandum in Support of Motion for Revision of Schedule Re Daubert Challenge Concerning Short-Term Use and Lobular Cancer filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2853 MOTION for Order Motion for Revision of Schedule re Daubert Challenge Concerning Short-Term Use and Lobular Cancer by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2852 RESPONSE to Motion re 2837 SEALED MOTION Surreply Re the PSC's Global Motion in Limine Under Seal filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2851 REPLY to Response to Motion re 2837 SEALED MOTION filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 2850 REPLY to Response to Motion re #2846 MOTION for Order to Permit Expert Testimony at Upcoming Daubert Proceedings Via Live Video-Conferencing filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11)(Littlepage, Zoe) |
![]() |
Filing 2848 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2846 MOTION for Order to Permit Expert Testimony at Upcoming Daubert Proceedings Via Live Video-Conferencing, #2847 Brief in Support December 5, 2011 Letter from Lane Heard to Judge Wilson (Heard, F.) |
Filing 2847 BRIEF IN SUPPORT re #2846 Motion for Order to Permit Expert Testimony at Upcoming Daubert Proceedings Via Live Video-Conferencing filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
Filing 2846 MOTION for Order to Permit Expert Testimony at Upcoming Daubert Proceedings Via Live Video-Conferencing by Counsel Plaintiff Lead (Littlepage, Zoe) |
![]() |
![]() |
![]() |
Filing 2842 Unopposed MOTION for Extension of Time to File Response/Reply as to #2834 MOTION for Order Motion to Bar All Testimony of Dr. Bruce Patsner by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 2841 SEALED RESPONSE in Opposition re 2837 SEALED MOTION re Dr. Bruce Patsner filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) (The document was removed from the docket and filed under seal on 11/29/2011 and docket text remained descriptive, pursuant to instructions from Chambers. ) (thd) |
NOTICE OF DOCKET CORRECTION re: #2841 RESPONSE in Opposition re 2837 SEALED MOTION re Dr. Bruce Patsner filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. CORRECTION: The document was removed from the docket and filed under seal, pursuant to instructions from Chambers. (thd) |
![]() |
NOTICE OF DOCKET CORRECTION re 2837 SEALED MOTION: docket text modified at the instructions of the Court to read.... "Sealed Motion in Limine regarding Dr. Bruce Patsner". (bfw) |
Filing 2839 RESPONSE in Opposition re #2830 MOTION for Order Plaintiffs' Motion for Alternate Hearing Date for Daubert Hearing on Her2-Neu Positive Cancer filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
Filing 2836 MOTION to Withdraw as Attorney Clayborne S. Stone and Williams and Anderson PLC by Novartis Pharmaceuticals Corporation (Stone, Clayborne) |
Filing 2838 SEALED BRIEF (tjj) |
Filing 2837 SEALED MOTION in Limine regarding Dr. Bruce Patsner(tjj) (docket text modified on 11/23/2011 at the instructions of the Court) (bfw). |
Filing 2835 BRIEF IN SUPPORT re #2834 Motion for Order Motion to Bar All Testimony of Dr. Bruce Patsner filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit #1, #2 Exhibit #2)(Heard, F.) |
Filing 2834 MOTION for Order Motion to Bar All Testimony of Dr. Bruce Patsner by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2833 RESPONSE to Motion re #2815 Second MOTION to Remand PPO-9, Wave 5 Cases filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Heard, F.) |
![]() |
Filing 2831 BRIEF IN SUPPORT re #2830 Motion for Order Plaintiffs' Motion for Alternate Hearing Date for Daubert Hearing on Her2-Neu Positive Cancer filed by Counsel Plaintiff Lead. (Littlepage, Zoe) |
Filing 2830 MOTION for Order Plaintiffs' Motion for Alternate Hearing Date for Daubert Hearing on Her2-Neu Positive Cancer by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 2829 NOTICE: Daubert Hearing re: HER2-Neu Positive Cancer set for 1/26/2012 at 10:00 AM in Little Rock Courtroom #A401 before Judge Billy Roy Wilson. (maj) |
REMARK: Receipt of electronic record from USDC Eastern District of Louisiana, 2:11-cv-2649 Cain, et al v. Wyeth, et al (OUR CASE NO. 4:11-cv-819 BRW).(tjj) |
REMARK: Receipt of electronic record from USDC Northern District of Mississippi, 2:11-cv-175 Kendrick v. Wyeth, Inc., et al (OUR CASE NO. 4:11-cv-820 BRW). (tjj) |
REMARK: Receipt of electronic record from USDC Northern District of Mississippi, Jones v. Wyeth, et al 2:11-cv-176 (OUR CASE NO. 4:11-cv-821 BRW). (tjj) |
Filing 2828 CONDITIONAL TRANSFER ORDER (CTO-219) from the Judicial Panel of Multidistrict Litigation that the 3 actions listed in this Order now pending in the Eastern District of Louisiana (1) and the Northern District of Mississippi (2) are now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 11/14/11. (tjj) |
Filing 2827 REPLY to Response to Motion re #2806 MOTION for Relief Daubert Proceeding Related to Obese Plaintiffs filed by Wyeth Inc. (Attachments: #1 Exhibit 70, #2 Exhibit 71, #3 Exhibit 72)(Heard, F.) |
![]() |
Filing 2825 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc re #2823 Order, November 8, 2011 Letter from Lane Heard to Judge Wilson (Heard, F.) |
Filing 2824 NOTICE by Counsel Plaintiff Lead re #2823 Order, Letter from Zoe Littlepage to Judge Wilson (Littlepage, Zoe) |
![]() |
Filing 2822 NOTICE by Counsel Plaintiff Lead Plaintiffs' Submission of Supplemental Authority Re Daubert Orders In Her2 Positive (ER+/HER2+) Breast Cancer Cases (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Littlepage, Zoe) |
Filing 2821 NOTICE by Wyeth Inc, Wyeth Pharmaceuticals Inc Submission Re Daubert Hearing Re HER2-Positive Breast Cancer Causation (Heard, F.) |
![]() |
REMARK: Receipt of electronic record from USDC Northern District of Ohio, 3:11-cv-2157, Riegle, et al v. Wyeth, et al (OUR CASE NO. 4:11-cv-787 BRW).(tjj) |
Filing 2819 REPLY to Response to Motion re #2810 MOTION to Compel Waiver Letter filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit #1, #2 Exhibit #2)(Heard, F.) |
Filing 2818 REPLY to Response to Motion re #2808 MOTION to Compel , or In the Alternative MOTION to Strike Expert Witness Designation filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit Exhibit #1)(Heard, F.) |
Filing 2817 RESPONSE in Opposition re #2806 MOTION for Relief Daubert Proceeding Related to Obese Plaintiffs filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12)(Littlepage, Zoe) |
Filing 2816 BRIEF IN SUPPORT re #2815 Motion to Remand PPO-9, Wave 5 Cases filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
Filing 2815 Second MOTION to Remand PPO-9, Wave 5 Cases by Counsel Plaintiff Lead (Littlepage, Zoe) |
Filing 2814 RESPONSE in Opposition re #2810 MOTION to Compel Waiver Letter filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Littlepage, Zoe) |
Filing 2813 RESPONSE in Opposition re #2808 MOTION to Compel , or In the Alternative MOTION to Strike Expert Witness Designation filed by Counsel Plaintiff Lead. (Attachments: #1 Exhibit 1)(Littlepage, Zoe) |
Filing 2812 CONDITIONAL TRANSFER ORDER (CTO-218) from the Judicial Panel of Multidistrict Litigation that the 1 action listed in this Order now pending in the Northern District of Ohio (1) is now transferred to the Eastern District of Arkansas as part of MDL-1507. Signed by the Clerk of the MDL Panel on 10/28/11 (tjj) |
Filing 2811 BRIEF IN SUPPORT re #2810 Motion to Compel Waiver Letter filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Heard, F.) |
Filing 2810 MOTION to Compel Waiver Letter by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2809 BRIEF IN SUPPORT re #2808 Motion to Strike, Motion to Compel Memorandum in Support of Motion to Compel or, In the Alternative, to Strike Expert Witness Designation filed by Wyeth Inc, Wyeth Pharmaceuticals Inc. (Attachments: #1 Exhibit 1)(Heard, F.) |
Filing 2808 MOTION to Compel , or In the Alternative, MOTION to Strike Expert Witness Designation () by Wyeth Inc, Wyeth Pharmaceuticals Inc (Heard, F.) |
Filing 2807 BRIEF IN SUPPORT re #2806 Motion for Relief for a Daubert Proceeding Related to Obese Plaintiffs filed by Wyeth Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Document 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55, #56 Exhibit 56, #57 Exhibit 57, #58 Exhibit 58, #59 Exhibit 59, #60 Exhibit 60, #61 Exhibit 61, #62 Exhibit 62, #63 Exhibit 63, #64 Exhibit 64, #65 Exhibit 65, #66 Exhibit 66, #67 Exhibit 67, #68 Exhibit 68, #69 Exhibit 69)(Heard, F.) |
Filing 2806 MOTION for Relief Daubert Proceeding Related to Obese Plaintiffs by Wyeth Inc (Heard, F.) |
Filing 2805 NOTICE by Counsel Plaintiff Lead Plaintiffs' Submission Re Short Term Use and Lobular Cancer and Natural Progesterone as a Safer Alternative (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 7 - 1, #9 Exhibit 7 - 2, #10 Exhibit 7 - 3, #11 Exhibit 7 - 4, #12 Exhibit 7 - 5, #13 Exhibit 7 - 6, #14 Exhibit 7 - 7, #15 Exhibit 7 - 8, #16 Exhibit 7 - 9, #17 Exhibit 7 - 10, #18 Exhibit 7 - 12, #19 Exhibit 7 - 13, #20 Exhibit 7 - 14, #21 Exhibit 7 - 15, #22 Exhibit 7 - 16, #23 Exhibit 7 - 17, #24 Exhibit 7 - 18, #25 Exhibit 7 - 19, #26 Exhibit 7 - 20, #27 Exhibit 7 - 21, #28 Exhibit 7 - 22, #29 Exhibit 7 - 23, #30 Exhibit 7 - 24, #31 Exhibit 7 - 25, #32 Exhibit 7 - 26, #33 Exhibit 7 - 27, #34 Exhibit 7 - 28, #35 Exhibit 7 - 29, #36 Exhibit 7 - 30, #37 Exhibit 7 - 31, #38 Exhibit 7 - 32, #39 Exhibit 7 - 33, #40 Exhibit 7 - 34, #41 Exhibit 7 - 35, #42 Exhibit 7 - 36, #43 Exhibit 7 - 37, #44 Exhibit 7 - 38, #45 Exhibit 7 - 39, #46 Exhibit 7 - 40, #47 Exhibit 7 - 41, #48 Exhibit 7 - 42, #49 Exhibit 7 - 43, #50 Exhibit 7 - 44, #51 Exhibit 7 - 45, #52 Exhibit 7 - 46, #53 Exhibit 7 - 47, #54 Exhibit 7 - 48, #55 Exhibit 7 - 49, #56 Exhibit 7 - 50, #57 Exhibit 7 - 51, #58 Exhibit 7 - 52, #59 Exhibit 7 - 53, #60 Exhibit 7 - 54, #61 Exhibit 7 - 55, #62 Exhibit 7 - 56, #63 Exhibit 7 - 57, #64 Exhibit 7 - 58, #65 Exhibit 7 - 59, #66 Exhibit 7 - 60, #67 Exhibit 7 - 61, #68 Exhibit 7 - 62, #69 Exhibit 7 - 63, #70 Exhibit 7 - 64, #71 Exhibit 7 - 65, #72 Exhibit 7 - 66, #73 Exhibit 7 - 67, #74 Exhibit 7 - 68, #75 Exhibit 7 - 69, #76 Exhibit 7 - 70, #77 Exhibit 7 - 71, #78 Exhibit 7 - 72, #79 Exhibit 7 - 73, #80 Exhibit 7 - 74, #81 Exhibit 7 - 75, #82 Exhibit 7 - 76, #83 Exhibit 7 - 77, #84 Exhibit 7 - 78, #85 Exhibit 7 - 79, #86 Exhibit 7 - 80, #87 Exhibit 7 - 81, #88 Exhibit 7 - 82, #89 Exhibit 7 - 83, #90 Exhibit 7 - 84, #91 Exhibit 7 - 85, #92 Exhibit 7 - 86, #93 Exhibit 7 - 87, #94 Exhibit 7 - 88, #95 Exhibit 7 - 89, #96 Exhibit 7 - 90, #97 Exhibit 7 - 91, #98 Exhibit 7 - 92, #99 Exhibit 7 - 93, #100 Exhibit 7 - 94, #101 Exhibit 7 - 95, #102 Exhibit 7 - 96, #103 Exhibit 7 - 98, #104 Exhibit 7 - 99, #105 Exhibit 7 - 100, #106 Exhibit 7 - 101, #107 Exhibit 7 - 102, #108 Exhibit 7 - 103, #109 Exhibit 7 - 104, #110 Exhibit 7 - 105, #111 Exhibit 7 - 106, #112 Exhibit 7 - 107, #113 Exhibit 7 - 108, #114 Exhibit 7 - 109, #115 Exhibit 7 - 110, #116 Exhibit 7 - 111, #117 Exhibit 7 - 112, #118 Exhibit 7 - 113, #119 Exhibit 7 - 114, #120 Exhibit 7 - 115, #121 Exhibit 7 - 116, #122 Exhibit 7 - 117, #123 Exhibit 7 - 118, #124 Exhibit 7 - 119, #125 Exhibit 7 - 120, #126 Exhibit 7 - 121, #127 Exhibit 8, #128 Exhibit 9, #129 Exhibit 10)(Littlepage, Zoe) |
![]() |